Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.530
-0.160 (-9.47%)
Jun 27, 2025, 4:00 PM - Market closed
Intelligent Bio Solutions Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2017 - 2019 |
| Operating Revenue | 2.94 | 3.11 | 1.26 | - | - | - | Upgrade
|
| Other Revenue | - | - | - | - | 1.98 | 0.19 | Upgrade
|
| Revenue | 2.94 | 3.11 | 1.26 | - | 1.98 | 0.19 | Upgrade
|
| Revenue Growth (YoY) | 3.87% | 147.58% | - | - | 949.30% | - | Upgrade
|
| Cost of Revenue | 1.21 | 1.69 | 0.93 | - | - | - | Upgrade
|
| Gross Profit | 1.73 | 1.43 | 0.33 | - | 1.98 | 0.19 | Upgrade
|
| Selling, General & Admin | 8.84 | 9.26 | 8.03 | 4.92 | 3.36 | 2.2 | Upgrade
|
| Research & Development | 2.56 | 1.67 | 0.51 | 3.85 | 3.84 | 0.59 | Upgrade
|
| Other Operating Expenses | -0.51 | -0.42 | -0.74 | -0.44 | - | - | Upgrade
|
| Operating Expenses | 12.08 | 11.71 | 8.76 | 8.34 | 7.19 | 2.79 | Upgrade
|
| Operating Income | -10.35 | -10.28 | -8.44 | -8.34 | -5.21 | -2.6 | Upgrade
|
| Interest Expense | -0.11 | -0.17 | -0.22 | -0.01 | -1.09 | -0.46 | Upgrade
|
| Interest & Investment Income | 0.16 | 0.08 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0.14 | 0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0.01 | -0 | -0.27 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.18 | 2.15 | - | -0.36 | -0.25 | Upgrade
|
| EBT Excluding Unusual Items | -10.3 | -10.19 | -6.51 | -8.33 | -7.06 | -3.19 | Upgrade
|
| Impairment of Goodwill | - | - | -4.16 | - | - | - | Upgrade
|
| Pretax Income | -10.3 | -10.19 | -10.66 | -8.33 | -7.06 | -3.19 | Upgrade
|
| Earnings From Continuing Operations | -10.3 | -10.19 | -10.66 | -8.33 | -7.06 | -3.19 | Upgrade
|
| Minority Interest in Earnings | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | Upgrade
|
| Net Income | -10.26 | -10.16 | -10.63 | -8.31 | -7.04 | -3.16 | Upgrade
|
| Net Income to Common | -10.26 | -10.16 | -10.63 | -8.31 | -7.04 | -3.16 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 2 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 2 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 398.83% | 1802.54% | 37.00% | 40.81% | 22.38% | 1.52% | Upgrade
|
| EPS (Basic) | -2.40 | -6.38 | -127.00 | -135.93 | -162.17 | -89.22 | Upgrade
|
| EPS (Diluted) | -2.40 | -6.38 | -127.00 | -135.93 | -162.17 | -89.22 | Upgrade
|
| Free Cash Flow | -10.6 | -9.79 | -7.88 | -3.74 | -11.3 | -0.5 | Upgrade
|
| Free Cash Flow Per Share | -2.48 | -6.15 | -94.16 | -61.18 | -260.32 | -14.06 | Upgrade
|
| Gross Margin | 58.81% | 45.81% | 25.99% | - | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -352.62% | -330.46% | -671.24% | - | -263.28% | -1378.90% | Upgrade
|
| Profit Margin | -349.50% | -326.40% | -845.89% | - | -355.33% | -1676.23% | Upgrade
|
| Free Cash Flow Margin | -361.05% | -314.71% | -627.15% | - | -570.39% | -264.18% | Upgrade
|
| EBITDA | -9.4 | -9.31 | -7.62 | - | - | - | Upgrade
|
| EBITDA Margin | - | -299.15% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.95 | 0.97 | 0.81 | - | - | - | Upgrade
|
| EBIT | -10.35 | -10.28 | -8.44 | -8.34 | -5.21 | -2.6 | Upgrade
|
| EBIT Margin | - | - | - | - | -263.28% | - | Upgrade
|
| Revenue as Reported | - | - | - | - | 1.98 | 0.19 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.